The prescribing gap: Why specialty drugs stall before patients start therapy, a podcast sponsored...

Pharma brands invest millions to bring specialty medications to market — and then watch patients abandon therapy before it begins. The culprit is friction within the prescribing workflow: prior authorization requirements that providers don’t anticipate, scripts sent to a pharmacy that can’t fill them and administrative complexity that makes physicians hesitant to prescribe in the first place. DrFirst chief medical officer Dr. Colin Banas and EVP, corporate strategy Drew Hunsinger join The MM+M Podcast to discuss what happens between the moment a physician decides to prescribe a specialty medication and the moment a patient starts therapy, and what that means for your brand performance. They'll explore how embedding intelligent decision support directly into the prescribing workflow helps providers write clean prescriptions that arrive at the pharmacy ready to fill, and why solving this upstream problem is the next frontier for pharma access strategy. Check us out at: mmm-online.com (https://www.mmm-online.com/)   Follow us:  YouTube: @MMM-online (   / @mmm-online  ) TikTok: @MMMnews (  / mmmnews  ) Instagram: @MMMnewsonline (  / mmmnewsonline  ) Twitter/X: @MMMnews (  / mmmnews  ) LinkedIn: MM+M (  / medical-marketing-media-mmm  )   To read more of the most timely, balanced and original reporting in medical marketing, subscribe here. (https://forms.haymarketsubscribe.com/...) Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.